HomeCompareHSRMF vs JNJ

HSRMF vs JNJ: Dividend Comparison 2026

HSRMF yields 666.67% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HSRMF wins by $608115.63M in total portfolio value
10 years
HSRMF
HSRMF
● Live price
666.67%
Share price
$0.30
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$608115.66M
Annual income
$469,561,018,816.25
Full HSRMF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — HSRMF vs JNJ

📍 HSRMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHSRMFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HSRMF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HSRMF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HSRMF
Annual income on $10K today (after 15% tax)
$56,666.67/yr
After 10yr DRIP, annual income (after tax)
$399,126,865,993.81/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, HSRMF beats the other by $399,126,861,956.41/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HSRMF + JNJ for your $10,000?

HSRMF: 50%JNJ: 50%
100% JNJ50/50100% HSRMF
Portfolio after 10yr
$304057.84M
Annual income
$234,780,511,783.06/yr
Blended yield
77.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

HSRMF
No analyst data
Altman Z
-0.6
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HSRMF buys
0
JNJ buys
0
No recent congressional trades found for HSRMF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHSRMFJNJ
Forward yield666.67%2.14%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$608115.66M$30.5K
Annual income after 10y$469,561,018,816.25$4,749.88
Total dividends collected$596792.85M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HSRMF vs JNJ ($10,000, DRIP)

YearHSRMF PortfolioHSRMF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$77,367$66,666.67$10,594$274.49+$66.8KHSRMF
2$564,818$482,035.31$11,294$360.69+$553.5KHSRMF
3$3,893,246$3,288,890.67$12,133$476.91+$3.88MHSRMF
4$25,352,760$21,186,987.16$13,156$635.42+$25.34MHSRMF
5$156,070,781$128,943,327.59$14,432$854.61+$156.06MHSRMF
6$908,837,800$741,842,064.29$16,056$1,162.76+$908.82MHSRMF
7$5,009,769,782$4,037,313,336.56$18,175$1,604.53+$5009.75MHSRMF
8$26,159,339,258$20,798,885,591.56$21,009$2,252.68+$26159.32MHSRMF
9$129,490,317,125$101,499,824,118.87$24,911$3,229.73+$129490.29MHSRMF
10$608,115,658,140$469,561,018,816.25$30,458$4,749.88+$608115.63MHSRMF

HSRMF vs JNJ: Complete Analysis 2026

HSRMFStock

Hastings Technology Metals Limited engages in the exploration and development of rare earth deposits in Australia. The company focuses on neodymium and praseodymium minerals. Its flagship project is the Yangibana Rare Earths Project, which holds 100% interests in 6 mining leases, 2 prospecting licenses, 11 exploration licenses, 5 general purpose leases, and 13 miscellaneous licenses; and 70% interests in 3 mining leases, 8 exploration licenses, and 2 general purpose leases that covers an area of 650 sq km area located in the Gascoyne region of Western Australia. The company was formerly known as Hastings Rare Metals Limited and changed its name to Hastings Technology Metals Limited in October 2015. Hastings Technology Metals Limited was incorporated in 2006 and is based in Perth, Australia.

Full HSRMF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this HSRMF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HSRMF vs SCHDHSRMF vs JEPIHSRMF vs OHSRMF vs KOHSRMF vs MAINHSRMF vs ABBVHSRMF vs MRKHSRMF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.